Ignite Creation Date:
2025-12-24 @ 7:02 PM
Ignite Modification Date:
2026-01-20 @ 6:08 PM
Study NCT ID:
NCT02598557
Status:
COMPLETED
Last Update Posted:
2023-08-22
First Post:
2015-11-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Stage 0 Breast Cancer AJCC v6 and v7 | View |
| None | Stage I Breast Cancer AJCC v7 | View |
| None | Stage IA Breast Cancer AJCC v7 | View |
| None | Stage IB Breast Cancer AJCC v7 | View |
| None | Stage II Breast Cancer AJCC v6 and v7 | View |
| None | Stage IIA Breast Cancer AJCC v6 and v7 | View |
| None | Stage IIB Breast Cancer AJCC v6 and v7 | View |
Keywords: